| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ADAMTS like 3 | 0.729 | 0.346 | 1.4E-19 |
|
disease | 0.410 | None | 1.000 | 1 | 2 | 2009 | 2019 | ||||||||
|
EMAP like 5 | 0.821 | 0.231 | 5.7E-07 |
|
disease | 0.410 | None | 1.000 | 1 | 1 | 2009 | 2011 | ||||||||
|
coiled-coil domain containing 60 | 0.931 | 0.154 | 7.7E-10 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
STARD4 antisense RNA 1 | 0.890 | 0.115 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | |||||||||
|
phosphodiesterase 4D | 0.519 | 0.846 | 1.00 |
|
disease | 0.420 | None | 1.000 | 1 | 1 | 2009 | 2019 | ||||||||
|
solute carrier organic anion transporter family member 6A1 | 0.412 | 0.885 | 2.9E-11 |
|
disease | 0.180 | None | 1.000 | 1 | 1 | 2009 | 2018 | ||||||||
|
butyrophilin subfamily 2 member A2 | 0.839 | 0.346 | 1.4E-11 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2009 | 2017 | ||||||||
|
myosin XVIIIB | 0.628 | 0.615 | 1.0E-31 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
solute carrier family 17 member 3 | 0.769 | 0.385 | 4.9E-22 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2009 | 2015 | ||||||||
|
phospholipase A2 activating protein | 0.597 | 0.692 | 0.47 |
|
disease | 0.410 | None | 1.000 | 1 | 1 | 2010 | 2011 | ||||||||
|
2,4-dienoyl-CoA reductase 1 | 0.426 | 0.885 | 4.5E-14 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2010 | 2011 | ||||||||
|
tripartite motif containing 26 | 0.705 | 0.577 | 0.18 |
|
disease | 0.100 | None | 1.000 | 3 | 2 | 2011 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2011 | 2019 | |||||||||
|
mitotic arrest deficient 1 like 1 | 0.570 | 0.731 | 6.8E-16 |
|
disease | 0.440 | None | 1.000 | 3 | 3 | 2011 | 2020 | ||||||||
|
piggyBac transposable element derived 1 | 0.821 | 0.269 | 4.7E-10 |
|
disease | 0.430 | None | 0.800 | 3 | 2 | 2011 | 2014 | ||||||||
|
CUB and Sushi multiple domains 1 | 0.610 | 0.500 | 1.00 |
|
disease | 0.700 | None | 1.000 | 2 | 3 | 2011 | 2020 | ||||||||
|
BORCS7-ASMT readthrough (NMD candidate) | 0.805 | 0.154 |
|
disease | 0.100 | None | 1.000 | 2 | 2 | 2011 | 2019 | |||||||||
|
serologically defined colon cancer antigen 8 | 0.619 | 0.577 | 1.2E-11 |
|
disease | 0.410 | None | 1.000 | 2 | 3 | 2011 | 2019 | ||||||||
|
5'-nucleotidase, cytosolic II | 0.537 | 0.846 | 2.1E-06 |
|
disease | 0.140 | None | 1.000 | 2 | 1 | 2011 | 2019 | ||||||||
|
calcium voltage-gated channel subunit alpha1 S | 0.595 | 0.692 | 6.3E-12 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
cyclin and CBS domain divalent metal cation transport mediator 2 | 0.641 | 0.346 | 1.00 |
|
disease | 0.450 | None | 1.000 | 1 | 1 | 2011 | 2019 | ||||||||
|
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha | 0.633 | 0.692 | 1.0E-02 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2011 | 2017 | ||||||||
|
glycosyltransferase like domain containing 1 | 0.890 | 0.115 | 1.0E-12 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
nuclear factor of activated T cells 2 | 0.525 | 0.731 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2017 | ||||||||
|
chemokine like factor | 0.682 | 0.538 | 4.9E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 |